Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Experimental cancer drugs
Imexon
Другие языки:

Imexon

Подписчиков: 0, рейтинг: 0
Imexon
Imexon.svg
Clinical data
ATC code
  • none
Identifiers
  • 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard 100.056.199
Chemical and physical data
Formula C4H5N3O
Molar mass 111.104 g·mol−1
3D model (JSmol)
  • O=C1/N=C(/N)C2N1C2
  • InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8) ☒N
  • Key:BIXBBIPTYBJTRY-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

  • Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.



Новое сообщение